AstraZeneca Pharma India Ltd. announced its financial results for the quarter ending December 31, 2024, reporting a total income of Rs 44,827 lakhs and a net profit of Rs 3,085 lakhs. The company also shared plans to exit its manufacturing site, estimating it will take over 12 months and accounting for a provision of Rs 575.6 million related to this closure.